Trazodone is not a treatment for restless leg syndrome (RLS), and no clinical trials have tested whether it directly reduces the urge-to-move sensations that define the condition. The picture is complicated: one review in Neurotherapeutics lists trazodone among alternatives that “do not worsen RLS,” yet the American Academy of Sleep Medicine flags serotonergic medications, a category that includes trazodone, as potential exacerbating factors. What this means in practice is that trazodone occupies a gray zone, neither proven helpful nor clearly harmful, and the answer depends largely on why you’re considering it.
Why Trazodone Comes Up in RLS Conversations
Most people searching this topic are dealing with two overlapping problems: RLS symptoms and poor sleep. Trazodone is one of the most commonly prescribed off-label sleep aids in the United States, so it’s natural to wonder whether it could pull double duty. The short answer is that trazodone may help you fall and stay asleep without triggering the leg symptoms that many other antidepressants cause, but it is not targeting the RLS itself.
The distinction matters. First-line RLS treatments work by addressing the neurological drivers of the condition, primarily low dopamine signaling and, in many cases, low iron levels in the brain. Trazodone does neither of those things. Its main sleep-promoting effects come from blocking histamine receptors, certain serotonin receptors, and adrenaline-related receptors, which collectively quiet the brain’s arousal systems and promote deeper sleep.
How Trazodone Differs From SSRIs
If you’ve been told to avoid antidepressants because of your RLS, you may have heard a blanket warning that doesn’t fully apply to trazodone. Standard SSRIs like sertraline, fluoxetine, and escitalopram are well documented to worsen RLS and increase periodic leg movements during sleep. A large study of dialysis patients found that antidepressant use was associated with more than double the odds of an RLS diagnosis, with SSRIs prominently represented.
Trazodone works differently. It belongs to a class called serotonin antagonist and reuptake inhibitors (SARIs). While it does block the serotonin transporter like an SSRI, it simultaneously blocks the 5-HT2A and 5-HT2C serotonin receptors. This dual action is why trazodone avoids many of the side effects associated with SSRIs, including insomnia, anxiety, and sexual dysfunction. A study in the Journal of Clinical Sleep Medicine found that children taking trazodone had significantly fewer periodic leg movements during sleep than children on SSRIs, and their leg movement patterns more closely resembled those of children not taking any medication at all.
That said, trazodone is still serotonergic, and individual case reports have linked it to RLS worsening. The American Academy of Sleep Medicine’s 2025 clinical practice guideline recommends that managing RLS should start with addressing exacerbating factors, and serotonergic medications are on that list. So while trazodone appears to be better tolerated than SSRIs, it is not entirely risk-free for people with RLS.
What Trazodone Actually Does for Sleep
Where trazodone does have solid evidence is in improving sleep structure, which can be genuinely useful if RLS is fragmenting your nights. A systematic review and meta-analysis found that trazodone increased total sleep time by roughly 40 minutes compared to controls. It also significantly boosted the amount of deep sleep (stage N3), which is the most physically restorative phase. At the same time, it reduced the lighter, less restful stage of sleep (N1), decreased the number of awakenings, and cut down the time spent lying awake after initially falling asleep.
These improvements happened at both low and high doses, and held up over both short and long treatment courses. At the low doses typically used for sleep (25 to 100 mg), trazodone’s short half-life of three to six hours means it promotes sleep without dragging you into next-day drowsiness, and it doesn’t appear to cause tolerance over time.
For someone with RLS, this sleep-architecture benefit could be meaningful. RLS disrupts the transition into sleep and causes repeated awakenings, leading to chronic sleep deprivation that worsens daytime functioning, mood, and even pain perception. Getting more consolidated, deeper sleep won’t stop the leg sensations, but it can reduce the downstream damage they cause.
What Actually Treats RLS
If your RLS symptoms are frequent or moderate to severe, trazodone alone won’t be enough. The established first-line treatments target the condition’s root neurology. Gabapentinoids (gabapentin and pregabalin) are now generally preferred as initial therapy. They reduce the abnormal nerve signaling that drives RLS sensations and can also improve sleep quality directly.
Iron supplementation is recommended when blood ferritin levels are below a specific threshold, because iron is essential for dopamine production in the brain. Even people whose iron levels look “normal” on standard blood tests can have levels that are too low to support proper dopamine function.
Dopamine-boosting medications were once the go-to treatment but have fallen out of favor as a long-term option because of a phenomenon called augmentation, where symptoms gradually get worse and start appearing earlier in the day. They’re still used in some cases but with more caution than in the past.
Lifestyle factors also play a real role. Caffeine, alcohol, and antihistamines (the kind found in many over-the-counter sleep aids like diphenhydramine) can all make RLS worse. Addressing these triggers is considered the essential first step before adding any medication.
When Trazodone Might Make Sense
The most practical scenario for trazodone in someone with RLS is when sleep problems persist even after RLS-specific treatment has reduced the leg sensations, or when you also need an antidepressant and want to avoid one that will flare your symptoms. Among the antidepressant options, trazodone and bupropion are the two most commonly cited as less likely to aggravate RLS. Bupropion works primarily on dopamine and norepinephrine rather than serotonin, which may actually provide some RLS benefit, though the evidence for that is also limited.
If you’re currently taking trazodone and notice your RLS symptoms worsening, that connection is worth paying attention to. While trazodone is better tolerated than SSRIs for most people with RLS, individual responses vary, and it remains a serotonergic drug. Conversely, if you’ve been on trazodone for a while and your RLS is stable or well controlled, there’s no strong reason to stop it based on RLS concerns alone.